查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404656

消費者基因體學市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2023-2030 年

Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region (North America, Europe), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

消費者基因組學市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球消費者基因組學市場規模預計將達到72億美元，2023年至2030年複合年成長率為24.8%。

消費者和醫生對 DTC（直接面對消費者）套件的興趣不斷增加，DNA檢測套組銷量隨之增加，以及個體化基因組學的上升趨勢預計將在預測期內推動市場擴張。最常見的測試使用少量的基因變化來預測某些健康特徵，發現通用特徵並提供有關血統的提示。隨著這些測試可以揭示的健康資訊變得更加多樣化，越來越多的公司直接向消費者提供基因測試。

消費者和醫生對 DTC套件的興趣增加、技術進步、消費者基因組學應用的增加、政府支持政策以及個體化基因組學的上升趨勢是推動市場擴張的主要因素。例如，根據 ScienceDirect 的報導，直接面對消費者 (DTC) 的檢測將在 2022 年變得更加普及，因為無需醫生處方箋即可購買。

COVID-19 大流行可能會增加人們對健康的興趣，並鼓勵探索消費者基因組學等新穎、前沿的方法。因此，基於DNA的研發和生物資訊學正在加大力度，旨在為COVID-19創造診斷工具和有效的治療方法，預計市場在預測期內將保持顯著的成長率。

消費者基因組學市場報告亮點

  • 由於涉及最常見的親子鑑定類型，遺傳相關部分在 2022 年收益佔有率。
  • 溶解微針領域預計將在預測期內以最快的速度成長，因為它需要一個步驟，並且插入後無需移除微針。
  • FamilyTree DNA、AncestryDNA、23andMe, Inc. 和 MyHeritage 等公司提供多種父系和母系測試。這些測試提供了有關遺傳關係和血統的負擔得起的資訊。
  • 由於人們對 DTC 遺傳學的認知不斷增強，並且長期研究舉措的資金籌措，預計亞太地區在預測期內將經歷最快的複合年成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章消費者基因體學應用商業分析

  • 消費者基因體學市場：應用變異分析
  • 遺傳相關性
    • 2018-2030 年遺傳相關市場估計與預測
  • 祖先
    • 2018-2030 年 Ancestor 市場估計與預測
  • 生活方式、健康與營養
    • 2018-2030 年生活方式、健康和營養市場估計和預測
  • 診斷
    • 2018-2030 年診斷市場估計與預測
  • 運動營養與健康
    • 2018-2030年運動營養與健康市場估計與預測
  • 生殖健康
    • 2018-2030 年生殖健康市場估計與預測
  • 個人化醫療/藥物基因測試
    • 2018-2030 年個人化醫療/藥物基因學測試市場估計與預測
  • 其他
    • 2018-2030 年其他應用市場估計與預測

第5章區域業務分析

  • 消費者基因體學市場：區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Ancestry
    • 23andMe, Inc.
    • Gene by Gene, Ltd.
    • Mapmygenome
    • Color Health, Inc.
    • Positive Biosciences, Ltd.
    • Futura Genetics
    • Helix OpCo LLC
    • MyHeritage Ltd.
    • Pathway Genomics
    • Veritas
    • Myriad Genetics, Inc.
    • Illumina, Inc.
    • Amgen, Inc.
    • Xcode Life
    • Diagnomics, Inc.
    • Toolbox Genomics
Product Code: GVR-2-68038-987-6

Consumer Genomics Market Growth & Trends:

The global consumer genomics market size is expected to reach USD 7.20 billion by 2030, registering a CAGR of 24.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rise in consumer and physician interest in direct-to-consumer (DTC) kits, coupled with a subsequent increase in the sales of DNA test kits, and the growing trend of personalized genomics, are expected to drive market expansion over the forecast period. The most common tests utilize a small number of genetic changes to predict certain health characteristics, reveal common traits, and provide ancestry hints. With the expansion of the variety of health information these tests can uncover, an increasing number of companies are offering genetic testing directly to consumers.

The surge in consumer and physician interest in DTC kits, technological improvements, an increase in consumer genomics applications, supportive governmental policies, and the growing trend of personalized genomics are the primary drivers of market expansion. For instance, according to a ScienceDirect article, direct-to-consumer (DTC) tests became more prevalent in 2022 as they could be purchased without a doctor's prescription.

The COVID-19 pandemichas heightened people's concerns about their health, potentially encouraging them to explore novel and cutting-edge methods like consumer genomics. Therefore, the market is expected to maintain its considerable growth rate over the forecast period due to the increasing efforts in DNA-based research and development, as well as bioinformatics, aimed at creating diagnostic tools and efficient therapies for COVID-19.

Consumer Genomics Market Report Highlights:

  • The genetic relatedness segment accounted for the largest revenue share in 2022 due to its involvement in the most common type of paternal testing
  • The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period since it requires only one step, and the microneedle does not need to be removed after insertion
  • Companies such as FamilyTree DNA; AncestryDNA; 23andMe, Inc.; MyHeritage, and others offer several paternal and maternal tests. These tests provide information about genetic relations and ancestry at an affordable cost
  • Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to the increasing awareness related to DTC genetics and the availability of funding for long-term research initiatives

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segment & Scope
    • 1.1.1. Application
    • 1.1.2. Regional Scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Model
  • 1.5. Market Scope & Segment Definition
  • 1.6. Market Model
    • 1.6.1. Market Study, By Company Market Share
    • 1.6.2. Regional Analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
      • 3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
      • 3.2.1.3. Expansion in applications of DTC genetics
      • 3.2.1.3.1. Health testing
      • 3.2.1.3.2. Ancestry
      • 3.2.1.3.3. Genetic relatedness
      • 3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
      • 3.2.1.5. Growing trend of personalized genomics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
      • 3.2.2.2. Misleading results create challenges in adoption of home-based genetic tests
      • 3.2.2.3. Regulatory challenges pertaining to the use of DTC genetic tests
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Consumer Genomics Application Business Analysis

  • 4.1. Consumer Genomics Market: Application Movement Analysis
  • 4.2. Genetic Relatedness
    • 4.2.1. Genetic Relatedness Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Ancestry
    • 4.3.1. Ancestry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lifestyle, Wellness, & Nutrition
    • 4.4.1. Lifestyle, Wellness, & Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Diagnostics
    • 4.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sports Nutrition & Health
    • 4.6.1. Sports Nutrition & Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Reproductive Health
    • 4.7.1. Reproductive Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Personalized medicine & Pharmacogenetic testing
    • 4.8.1. Personalized medicine & Pharmacogenetic testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Other Application Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Consumer Genomics Market: Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Target Disease Prevalence
      • 5.2.2.3. Competitive Scenario
      • 5.2.2.4. Regulatory Framework
      • 5.2.2.5. U.S. Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Target Disease Prevalence
      • 5.2.3.3. Competitive Scenario
      • 5.2.3.4. Regulatory Framework
      • 5.2.3.5. Canada Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Target Disease Prevalence
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Regulatory Framework
      • 5.3.2.5. UK Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Target Disease Prevalence
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Regulatory Framework
      • 5.3.3.5. Germany Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Target Disease Prevalence
      • 5.3.4.3. Competitive Scenario
      • 5.3.4.4. Regulatory Framework
      • 5.3.4.5. France Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Target Disease Prevalence
      • 5.3.5.3. Competitive Scenario
      • 5.3.5.4. Regulatory Framework
      • 5.3.5.5. Italy Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Target Disease Prevalence
      • 5.3.6.3. Competitive Scenario
      • 5.3.6.4. Regulatory Framework
      • 5.3.6.5. Spain Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Target Disease Prevalence
      • 5.3.7.3. Competitive Scenario
      • 5.3.7.4. Regulatory Framework
      • 5.3.7.5. Denmark Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Target Disease Prevalence
      • 5.3.8.3. Competitive Scenario
      • 5.3.8.4. Regulatory Framework
      • 5.3.8.5. Sweden Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Target Disease Prevalence
      • 5.3.9.3. Competitive Scenario
      • 5.3.9.4. Regulatory Framework
      • 5.3.9.5. Norway Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Target Disease Prevalence
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Regulatory Framework
      • 5.4.2.5. Japan Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Target Disease Prevalence
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Regulatory Framework
      • 5.4.3.5. China Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Target Disease Prevalence
      • 5.4.4.3. Competitive Scenario
      • 5.4.4.4. Regulatory Framework
      • 5.4.4.5. India Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Target Disease Prevalence
      • 5.4.5.3. Competitive Scenario
      • 5.4.5.4. Regulatory Framework
      • 5.4.5.5. Australia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.6. Switzerland
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Target Disease Prevalence
      • 5.4.6.3. Competitive Scenario
      • 5.4.6.4. Regulatory Framework
      • 5.4.6.5. Switzerland Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Target Disease Prevalence
      • 5.4.7.3. Competitive Scenario
      • 5.4.7.4. Regulatory Framework
      • 5.4.7.5. Thailand Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.8. South Korea
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Target Disease Prevalence
      • 5.4.8.3. Competitive Scenario
      • 5.4.8.4. Regulatory Framework
      • 5.4.8.5. South Korea Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Target Disease Prevalence
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Regulatory Framework
      • 5.5.2.5. Brazil Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.3. Mexico
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Target Disease Prevalence
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Regulatory Framework
      • 5.5.3.5. Mexico Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.4. Argentina
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Target Disease Prevalence
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Regulatory Framework
      • 5.5.4.5. Argentina Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Target Disease Prevalence
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Regulatory Framework
      • 5.6.2.5. South Africa Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Target Disease Prevalence
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Regulatory Framework
      • 5.6.3.5. Saudi Arabia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Target Disease Prevalence
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. Regulatory Framework
      • 5.6.4.5. UAE Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Target Disease Prevalence
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Regulatory Framework
      • 5.6.5.5. Kuwait Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2022
  • 6.4. Company Profiles/Listing
    • 6.4.1. Ancestry
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. 23andMe, Inc.
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Gene by Gene, Ltd.
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Mapmygenome
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Color Health, Inc.
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Positive Biosciences, Ltd.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Futura Genetics
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Helix OpCo LLC
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. MyHeritage Ltd.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Pathway Genomics
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Veritas
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Myriad Genetics, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. Illumina, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Amgen, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives
    • 6.4.15. Xcode Life
      • 6.4.15.1. Overview
      • 6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic Initiatives
    • 6.4.16. Diagnomics, Inc.
      • 6.4.16.1. Overview
      • 6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic Initiatives
    • 6.4.17. Toolbox Genomics
      • 6.4.17.1. Overview
      • 6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of abbreviation
  • Table 3 Global consumer genomics market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 9 Europe consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 10 UK consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Germany consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 12 France consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 13 Italy consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Spain consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Denmark consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Sweden consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Japan consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 21 China consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 22 India consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Australia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Switzerland consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Mexico consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait consumer genomics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Consumer Genomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Consumer Genomics market: Application movement analysis
  • Fig. 15 Global Consumer Genomics market, for genetic relatedness, 2018 - 2030 (USD Million)
  • Fig. 16 Global Consumer Genomics market, for ancestry, 2018 - 2030 (USD Million)
  • Fig. 17 Global Consumer Genomics market, for lifestyle, wellness, & nutrition, 2018 - 2030 (USD Million)
  • Fig. 18 Global Consumer Genomics market, for diagnostics, 2018 - 2030 (USD Million)
  • Fig. 19 Global Consumer Genomics market, for sports nutrition & health, 2018 - 2030 (USD Million)
  • Fig. 20 Global Consumer Genomics market, for reproductive health, 2018 - 2030 (USD Million)
  • Fig. 21 Global Consumer Genomics market, for personalized medicine & pharmacogenetic testing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Consumer Genomics market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Consumer Genomics market: Region movement analysis
  • Fig. 26 North America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 32 France Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 40 China Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 41 India Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 43 Switzerland Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 53 UAE Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 54 Kuwait Consumer Genomics market, 2018 - 2030 (USD Million)